Finance School

​ Pharma Majors with US Facilities: Context of US Tariffs ​The companies with crucial advantage in the "Make in America" tariff environment. ​ Companies with Strongest Manufacturing Footprint (Highest Mitigation Potential): ​ Cipla: Leads the list with 5 US Manufacturing facilities and 2 R&D units (New York, Massachusetts). This is the strongest existing local production capacity, making it the best positioned to shift production and mitigate the impact of the new import tariffs. ​ Aurobindo: Has a significant presence with 4 US Manufacturing facilities and 4 R&D units (New Jersey, North Carolina, New York). Its extensive facilities provide a robust base to ramp up local production. ​ Piramal Pharma: Possesses 4 US Manufacturing facilities (Delaware, Kentucky, Michigan, Pennsylvania). This footprint, likely supporting its contract manufacturing business (CDMO), offers strategic flexibility for increasing US-based production. ​ Sun Pharma: Operates 3 US M...

 ### Naval Ravikant's Successful Investments Naval Ravikant has a prolific track record as an angel investor, with investments in over 131 companies across various sectors, particularly in technology and cryptocurrencies. While not every investment's outcome is publicly documented, several of his investments have achieved significant success, including:[](https://tracxn.com/d/people/naval-ravikant/__zjY_8gmflKDzBLSv520Gkf9qM24BNrfFb_Vo_boSVAQ) - **Uber**: Early-stage investment in the ride-hailing giant, which became a multi-billion-dollar company. - **Twitter**: Invested in the social media platform, which grew to become a global communication powerhouse. - **Yammer**: A workplace collaboration tool acquired by Microsoft for $1.2 billion in 2012. - **Notion**: A productivity and collaboration platform valued at $10 billion.[](https://www.trueup.io/naval-ravikant/companies) - **Vercel**: A frontend developer platform valued at $3.3 billion.[](https://www.trueup.io/naval-ravikan...